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Two Marek’s disease virus (MDV) cDNAs of 852 and 1168 bp, which map to the right end of the BamHI-I2 fragment of
the MDV genome, were isolated from a cDNA library derived from the MDV transformed lymphoblastoid cell line MKT-1.
These cDNAs hybridized to relatively abundant leftward mRNA transcripts in MKT-1 cells and cells lytically infected with
MDV. The transcriptional initiation site for these transcripts was located in the adjacent BamHI-Q2 fragment, as determined
by RNase protection and primer extension assays. A computer search for the presence of leftward open reading frames
(ORFs) revealed two ORFs encoding 135- and 195-amino-acid polypeptides. A polyclonal antibody raised against a protein
sequence in the N-terminus of the latter ORF detected a 23-kDa protein in the nuclear fraction of MDV-transformed
lymphoblastoid cells. Furthermore, this ORF was antisense to part of the MDV Eco-Q protein (Meq) sequence. q 1996
Academic Press, Inc.
Marek’s disease virus (MDV) is a cell-associated avian Viral gene transcription within the BamHI-H region in
IRL has been studied extensively. A gene family washerpesvirus that causes T-cell lymphoma in susceptible
chickens several weeks after infection (5, 18). A salient shown to be transcribed strictly in cells infected with
oncogenic MDV strains (2, 19). These transcripts werefeature of MDV is its ability to cause both productive
and latent infections. Among the three MDV serotypes, prematurely terminated in cells infected with nononco-
genic, attenuated MDV strains due to amplification of aserotype I is the oncogenic strain while serotypes II and
III are nononcogenic. The latter two as well as the attenu- 132-bp repeat located downstream of their promoter (3,
14). The BamHI-H gene family is composed of a total ofated serotype I strains have been used as effective vac-
cines for the prevention of the disease in susceptible six small open reading frames (ORFs) (19). However, the
significance of these ORFs with respect to MDV oncoge-chickens (8, 16, 29).
The MDV DNA is similar in structure to the DNAs of nicity and/or latency has yet to be determined.
the alphaherpesviruses in that a long unique sequence Another potential oncogene is the MDV Eco-Q protein,
(UL) and a short unique sequence (US) are flanked by the Meq, which is located within the BamHI-I2 and the adja-
inverted repeat sequences IRL/TRL and IRS/TRS , respec- cent BamHI-Q2 fragments in IRL (12). The Meq protein
tively (4, 6, 10). Analyses of MDV gene transcription in has been detected in MDV-transformed lymphoblastoid
lymphoma tissues obtained from infected chickens and cell lines as well as in cells lytically infected with MDV
in MDV-transformed lymphoblastoid tumor cell lines (12, 20). Its unique characteristics include a bZIP struc-
have demonstrated that viral gene transcription is limited ture resembling that of the jun/fos oncogene family (9,
to the inverted repeats flanking the UL and US sequences 11, 13) and a domain consisting of basic amino acids in
(23, 24, 27). Interestingly, the reiterated sequences flank- the N-terminus. The C-terminus of Meq contains a pro-
ing UL appear to be the most divergent among the various line-rich transactivating domain (21). Although Meq has
MDV serotypes (17). As a result, much attention has been not been shown directly to function as an oncogene, a
focused on the identification and characterization of viral recent study demonstrated that Meq is involved in the
transcripts that are encoded within these regions. maintenance of transformation by MDV (30).
Previous studies have shown that the right end of the
BamHI-I2 and the adjacent BamHI-Q2 fragments of theThe nucleotide sequences of the 852- and 1168-bp cDNAs have
been deposited with the GenBank Data Library under Accession Nos. MDV genome are highly transcribed in MDV-induced
U55025 and U55024, respectively.
lymphoblastoid tumors and tumor cell lines (12, 20, 27).1 To whom correspondence and reprint requests should be ad-
However, all of the transcripts characterized in thesedressed at Oncology Center, Johns Hopkins University, 418 N. Bond
St., Baltimore, MD 21231. Fax: (410) 955–0840. regions were shown to be transcribed in the rightward
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direction and detailed information regarding the leftward Mountain View, CA) revealed a consensus TATA element
in the BamHI-Q2 fragment (Figs. 1A and 2B). To determinetranscripts is lacking. To explore the transcriptional activ-
ity in the leftward direction in the above regions, we the transcriptional start site of the leftward transcripts,
RNase protection and primer extension assays were car-screened a cDNA library previously constructed from the
poly(A)/ RNA of the MDV nonproducer lymphoblastoid ried out (Figs. 2 and 3). The location and size as well as
primers (see below) used for PCR amplification of severalcell line MKT-1 (20), employing 32P-labeled ClaI–SalI and
SalI–BamHI subfragments of BamHI-I2 as probes (Fig. overlapping sense riboprobes used in the RNase protection
assays are shown in Fig. 2B. Primers 1 (5*-TATTATATATAA-1A). Two cDNA clones of sizes 852 and 1168 bp, whose
sequences were homologous to the right end of the CTAGGGG-3*) and 2 (5*-CATTCCCTCTTCTGCCCT-3*)
were used to amplify a 375-bp fragment (probe I) from aBamHI-I2 fragment of the MDV genome, were isolated
and subcloned directionally into SfiI–NotI sites of the cDNA clone encompassing the right end of the BamHI-I2
and adjacent BamHI-Q2 fragments reported previously (20).pGEM 11zf(/) vector (Promega Corp. Madison, WI). To
determine whether these cDNAs represented leftward Primers 3 (5*-ATGTGGGGGAGAT-3*) and 4 (5*-TTCTAC-
GCTCCGGGGCTCT-3*) were used to amplify a 337-bp frag-transcripts, they were used as templates to generate
sense riboprobes by in vitro transcription using T7 or ment (probe II) by RT–PCR from MKT-1 poly(A)/ RNA. Prim-
ers 3 and 5 (5*-CTCACCGGATGAACCTAACG-3*) wereSP6 polymerases in accordance with the manufacturer’s
instruction (Promega) and subsequently used for North- used to amplify a 593-bp fragment (probe III) by RT–PCR
from MKT-1 poly(A)/ fraction. All PCR and RT–PCR prod-ern blot analysis. The riboprobes were labeled with [a-
32P]CTP (800 Ci/mmol, New England Nuclear, Boston, ucts were cloned into pCRII vector, sequenced to confirm
their authenticity, and further used to generate riboprobesMA) and hybridized to MKT-1 poly(A)/ RNA essentially
as described previously (20). Total cellular RNA (7) was as described above. The RNase protection assays were
performed using the Ambion RPA kit (Ambion, Inc., Austin,used to prepare the poly(A)/ fraction by using a poly(A)/
mRNA isolation kit (Promega) in accordance with the TX) according to the manufacturer’s instructions.
As shown in Fig. 2A, probe I (375 bp), which extendsmanufacturer’s instructions.
As shown in Fig. 1B, a sense riboprobe prepared from 134 bp past the putative TATA element, protected a
175-bp fragment in MKT-1 cells, while probes II and IIIthe 852-bp cDNA detected two abundant leftward tran-
scripts of sizes 2.8 and 3.4 kb as well as three less abun- protected fragments as large as the full-length probes.
The 852-bp cDNA was also used as a probe in thesedant transcripts of 0.8, 1.6, and 1.8 kb. As a representative of
cells lytically infected with MDV, the nonpathogenic vaccine experiments (probe IV). The largest fragment protected
with this probe also corresponded to the size of thestrain, CVI988 (22) was used at a passage level greater
than 100. Essentially, the same transcripts were detected full-length probe (Fig. 2A). Taken together, the results
from the Northern blot analyses and RNase protectionin chicken embryo fibroblasts (CEF) infected with CVI988,
albeit to a lower level (Fig. 1B). None of the above tran- assays indicate that the 852-bp cDNA represents a
transcript that initiates from the TATA element locatedscripts were detected in UT-1, a lymphoblastoid cell line
infected with the reticuloendotheliosis virus, or CEF used in the adjacent BamHI-Q2 fragment (Figs. 1A and 2B).
The initiation site of this transcript, as determined byas negative controls. When a sense riboprobe generated
from the 1168-bp cDNA was used, only the 3.4-kb transcript primer extension using primer 2 (Fig. 2B), was mapped
to 59 bp downstream from this consensus TATA ele-was distinctly detected in MKT-1 cells (Fig. 1B). A transcript
of the same size was also detected with this probe in CEF ment (Fig. 3).
Since the 852-bp cDNA contains a potential poly(A)productively infected with CVI988 (not shown). In addition
to the cDNAs, another probe corresponding to sequences addition signal (not shown), it may represent either the
1.6- or the 1.8-kb transcript detected by Northern blotin the BamHI-Q2 and the adjacent BamHI-L fragments was
used (Fig. 1A, BamH-Q2 probe). This probe was constructed analysis when the 852-bp cDNA was used as a probe
(Fig. 1B). Transcripts of sizes 0.8 and 2.8 kb detected infrom MKT-1 poly(A)/ RNA by reverse transcriptase (RT)–
PCR, as described previously (20) using the primer set 5*- MKT-1 cells by this probe (Fig. 1B) may represent other
alternatively spliced transcripts. In support of this possi-CTTCTCCCCTAGTTATAT-3* and 5*-GAGAATTCAAACTAT-
TCTTG-3*. The PCR product was then cloned into the pCRII bility, we observed that probe IV also protected two dis-
crete fragments of 730 and 540 bp and several smallervector provided in the TA cloning kit (Invitrogen Corp., San
Diego, CA). A sense riboprobe generated from this con- fragments in MKT-1 cells (Fig. 2A). The very small frag-
ments, however, have most likely emerged from thestruct, however, did not detect any of the transcripts de-
tected by the two cDNAs in MKT-1 cells (Fig. 1B), sug- cleavage of hairpin structures formed within the RNA
probe due to its relatively large size. Moreover, se-gesting that the transcriptional start site of the leftward
transcripts maps to the right end of the BamHI-I2 or the quences within and flanking the 852-bp cDNA in the
corresponding genomic fragment contain a number ofadjacent BamHI-Q2 fragments. Indeed, a computer search
for the presence of the potential promoter/enhancer ele- splice donor and acceptor consensus sequences (15).
The 3.4-kb transcript detected by both cDNAs may bements in the above regions using the EUKPROM program
of the PC-GENE software release 6.8 (Intelligenetics, Inc., a nonspliced, readthrough transcript initiating from the
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FIG. 1. (A) Schematic representation of the MDV genome and location of BamHI-I2-specific cDNAs. TRL and IRL refer to terminal and internal long
repeats, respectively. TRS and IRS refer to terminal and internal short repeats, respectively. UL is the unique long sequence and US is the unique
short sequence. The BamHI-I2 and BamHI-Q2 fragments are enlarged in order to show the locations of the 852- and the 1168-bp cDNAs, as indicated
by the solid long arrows. The sizes of the cDNAs are indicated below each clone. ORF-2 refers to a potential ORF encoded by the 1168-bp cDNA,
while ORF-1 refers to an ORF encoded by the sequences within and upstream from the 5* end of the 852-bp cDNA, the latter of which is indicated
by the broken line. The location and orientation of the Meq ORF are also indicated. B, C, and Sa refer to BamHI, ClaI, and SalI restriction enzymes
sites. The solid bar indicates the location of a probe (BamH-Q2 probe) corresponding to sequences in the BamHI-Q2 and the adjacent BamHI-L
fragments used in Northern hybridization. (B) Detection of leftward transcripts by Northern hybridization. Poly(A)/ RNA (2 mg) from MKT-1, UT-1,
CEF, or CEF infected with CVI988 as described previously (10) were hybridized to sense riboprobes corresponding to the 852- and 1168-bp cDNAs,
and the BamHI-Q2 probe. The sizes of transcripts are indicated to the left. An RNA ladder from 0.24 to 9.5 kb was used as a size marker (GIBCO
BRL, Grand Island, NY).
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FIG. 2. RNase protection assay. (A) All riboprobes were hybridized with 2 mg poly(A)/ RNA from either MKT-1 (lanes 2–4, 7, 11, and 14) or UT-
1 (lanes 1, 8, 12, and 15) cells. Lanes 5, 6, 10, and 13 represent the undigested probes. In lanes 9 and 16, tRNA was substituted for MKT-1 RNA.
In lanes 2, 3, and 4, 0.5, 1, or 3 mg of MKT-1 mRNA was used, respectively. (B) A schematic showing the location of all probes. The arrows indicate
the position of primers used to amplify each probe (see text).
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in all three frames of translation within the genomic se-
quence encompassing the SalI–BamHI subfragment of
the BamHI-I2 and the consensus TATA element revealed
the presence of an ORF encoding a highly basic 195-
amino-acid polypeptide (Fig. 1A, ORF-1). To confirm the
presence of this ORF in MKT-1 poly(A)/ RNA, RT–PCR
and primers 3 and 5 (Fig. 2B) were used to amplify a
sequence corresponding to the entire ORF-1 from MKT-
1, but not UT-1 poly(A)/ RNA. This RT–PCR product was
amplified from RNA since no product was detected in
the absence of RT (data not shown). The entire nucleotide
sequence of this ORF was added to the sequence of the
852-bp cDNA and submitted to GenBank (Accession No.
U55025).
To detect the protein product encoded by ORF-1 in
MDV-infected cells, a rabbit polyclonal antibody was gen-
erated against the most antigenic protein sequence in
the N-terminus of ORF-1 (amino acids 1–111, corre-
sponding to nt 1–334). This sequence was obtained from
the plasmid containing the entire ORF-1 (probe II, Fig. 2B)
by restriction enzyme digestion and was subsequently
cloned into the BamHI–EcoRI site of the pGEX-4T-3 vec-
tor (Pharmacia, Piscataway, NJ) in-frame with the gluta-
thione S-transferase (GST) gene. The fusion protein was
then purified from the soluble fraction and injected intoFIG. 3. Determination of the transcriptional start site by primer exten-
two New Zealand rabbits essentially as described pre-sion assay. Twenty picomoles of primer 2 (see Fig. 2B) was end-labeled
with [g-32P]ATP (4500 Ci/mmol, ICN, Costa Mesa, CA) in a T4 poly- viously (20). The antisera were absorbed against the GST
nucleotide kinase reaction. Two picomoles of the labeled primer was protein and used for Western blot analysis. As shown in
then mixed with 1 mg poly(A)/ RNA from MKT-1 or UT-1 cells, denatured Fig. 4A, a protein of 23 kDa was detected in the nuclear
at 907, and incubated for 1 hr at 377 in a buffer containing 10 mM
fraction of MKT-1, but not UT-1 cells. This protein wasdithiothreitol, 25 U of RNase inhibitor, 0.5 mM dNTPs, and 100 U of M-
also detected in the nuclear fraction of MSB-1 cells (Fig.MLV RT (GIBCO BRL). Samples were ethanol precipitated and analyzed
on a 6% polyacrylamide–7 M urea gel. X174/HinfI DNA (Promega) was 4A, lane 1), another MDV-transformed lymphoblastoid
end-labeled and used as the size marker. The sizes (bp) are shown to cell line established with the BC-1 strain of MDV (1), as
the right. C refers to a control experiment in which the MKT-1 poly(A)/ well as in CEF productively infected with CVI988 (Fig.
RNA was used in the absence of RT. For determination of the initiation
4B, lanes 4 and 5), albeit to a lower level. Preimmunesite, the DNA sequence of part of probe I corresponding to sequences
sera did not show any immunoreactivity against this pro-upstream from the ATG codon of ORF-1 (Fig. 2B) was determined using
the same primer (2) and run in parallel. The arrow marks the initiation tein (not shown). At times, larger molecular weight pro-
start site. teins were also detected (Fig. 4A). However, we believe
that they represent inefficiently denatured protein com-
plexes, since they could be removed by prolonged boiling
consensus TATA element in the BamHI-Q2 fragment. In of the samples prior to loading on to the gel.
this context, it is important to note that a potential poly(A) A computer search for the presence of the potential ORFs
addition signal in the BamHI-I2 genomic sequence was within the 1168-bp cDNA revealed the presence of only
localized approximately 3.4 kb downstream of this TATA one ORF encoding a 135-amino-acid polypeptide (Fig. 1A,
element (Fig. 1A). The 3.4-kb transcript was the most ORF-2). A polyclonal rabbit antibody raised against a 10-
abundant transcript detected by the 1168-bp cDNA, al- amino-acid peptide sequence of ORF-2 did not detect any
though a less abundant transcript of 1.8 kb was also protein of the expected size in the MDV-infected cells (data
detected by this probe (Fig. 1B). It is unlikely that the not shown). However, the inability to detect the protein
1168-bp cDNA represents the former transcript since this product encoded by ORF-2 by this antiserum is most likely
cDNA contains a poly(A) tail (not shown), which is not due to generation of an inefficient immune response toward
present in the corresponding genomic sequence of the the very small immunogenic peptide employed. Experi-
GA strain (unpublished result). It may, however, represent ments are underway to generate an antibody against a
the 1.8-kb transcript and its 5* end may extend to the larger protein fragment of ORF-2.
SalI–BamHI subfragment of BamHI-I2 . Thus, further A comparison of the predicted amino acid sequence
cDNA cloning studies are required to obtain a complete of these ORFs with other known sequences in GenBank
representation of gene transcription in this region. did not yield any significant homology. However, one of
the striking features of ORF-1 is that it is antisense to partA computer search for the presence of potential ORFs
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FIG. 4. Immunodetection of the polypeptide encoded by ORF-1 in MDV-infected cells. (A) The nuclear (N) and cytoplasmic (C) fractions from MKT-
1 (lanes 2 and 5), MSB-1 (lanes 1 and 4), and UT-1 cells (lanes 3 and 6) were prepared according to Stein et al. (26), subjected to SDS–PAGE on
a 12.5% gel, and transferred to nitrocellulose. The antigen–antibody complexes were reacted with protein A conjugated to alkaline phosphatase
enzyme (Sigma Chemicals, St. Louis, MO), followed by the addition of 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Sigma), a
histochemical substrate for alkaline phosphatase. (B) Shows Western blot analyses of the nuclear (N) and cytoplasmic (C) fractions from CEF (lanes
2 and 6) or CEF infected with CVI988 for 9 (lanes 1 and 5) and 30 hr (lanes 3 and 4). The arrows in A and B point the position of the band
corresponding to the polypeptide encoded by ORF-1. M refers to the prestained, low-range molecular weight markers (Bio-Rad, Hercules, CA).
of the Meq sequence (Fig. 1A). In addition, a computer these transcripts could play a role in the establishment
and/or maintenance of latency by regulating the functionprediction for the secondary structure of the protein prod-
uct encoded by ORF-1 indicated that 67.1% of its residues of the gene(s) involved in the lytic infection.
assume a coil conformation. This feature as well as the
highly basic nature of this protein (p.i. value, 12.5) make ACKNOWLEDGMENTS
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